Optimal Management of ADHD in Pediatric Population

Theresa R. Cerulli, MD, provides an overview of the prevalence of attention-deficit/hyperactivity disorder (ADHD) in the pediatric population.

An expert psychiatrist explains the neuroscience of attention-deficit/hyperactivity disorder (ADHD) in the pediatric population.

An explanation of the typical predisposing factors in pediatric attention-deficit/hyperactivity disorder (ADHD).

Dr Theresa Cerulli comments on whether neuropsychological testing in children for attention-deficit/hyperactivity disorder (ADHD) is needed.

Theresa R. Cerulli, MD, describes the challenges comorbid psychiatric conditions pose in diagnosing attention deficit hyperactivity disorders (ADHD).

A neuropsychiatrist shares her thoughts on the relationship between substance abuse and attention-deficit/hyperactivity disorders (ADHD) in the pediatric population.

Theresa R. Cerulli, MD, reviews the use of viloxazine in managing pediatric attention-deficit/hyperactivity disorder (ADHD).

A key opinion leader considers the benefits of combining pharmacologic and nonpharmacologic treatments in the management of attention-deficit/hyperactivity disorder (ADHD) in children.

Dr. Theresa Cerulli reflects on exciting updates and unmet needs in the management and treatment of pediatric attention deficit hyperactivity disorders (ADHD).

Theresa R. Cerulli, MD, provides advice for clinicians on how to increase understanding of attention-deficit/hyperactivity disorders (ADHD) and encourage therapy adherence for both children and parents.